Mon-Fri 9:00-18:00 CET+39 095 7211344info@vitasanlabs.com

Family · Pharmaceutical analytical standards

Budesonide

A synthetic corticosteroid patented in 1973 and used for asthma since 1981. Today it is also used for COPD, allergic rhinitis and nasal polyps, Crohn's disease, colitis and, more recently, eosinophilic oesophagitis and IgA nephropathy. This family brings together the active ingredient, pharmacopoeial impurities, labelled standards and other impurities.

Did you know?About 80-90% of a swallowed dose is broken down by the liver on its first pass: this is why oral forms act mainly locally, in the gut.

BudesonideGo to the active ingredient →
BudesonideActive ingredientBudesonideCat. No. P-B131-001CAS 51333-22-3

EDQM standards 2

The official European Pharmacopoeia standards for this family.

Reference substanceBudesonide CRSEDQM code B1157300Family Budesonide

Need a molecule you cannot find?

Custom synthesis of impurities, metabolites and labelled compounds, with the same characterisation level.